661998 |
FRONTIERS IN ONCOLOGY |
Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer |
2021-03-05 |
10.3389/fonc.2021.631422 |
Lin Binwei, Huang Dan, Du Huan, Fan Jinjia, Zhang Yu, Feng Gang, Gao Feng, Du Xiao Bo |
661997 |
FRONTIERS IN ONCOLOGY |
Classification of Metastatic and Non-Metastatic Thoracic Lymph Nodes in Lung Cancer Patients Based on Dielectric Properties Using Adaptive Probabilistic Neural Networks |
2021-03-05 |
10.3389/fonc.2021.640804 |
Lu Di, Yu Hongfeng, Wang Zhizhi, Chen Zhiming, Fan Jiayang, Liu Xiguang, Zhai Jianxue, Wu Hua, Yu Xuefei, Cai Kaican |
661996 |
FRONTIERS IN ONCOLOGY |
Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer |
2021-03-05 |
10.3389/fonc.2021.642883 |
Xu Yanjun, Li Hui, Fan Yun |
661995 |
FRONTIERS IN ONCOLOGY |
Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment |
2021-03-05 |
10.3389/fonc.2021.651797 |
Molassiotis Alex, Yates Patsy, Yorke Janelle |
661994 |
FRONTIERS IN ONCOLOGY |
Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far? |
2021-03-05 |
10.3389/fonc.2021.630086 |
Demetter Pieter, Maréchal Raphaël, Puleo Francesco, Delhaye Myriam, Debroux Sébastien, Charara Fadi, Gomez Galdon Maria, Van Laethem Jean-Luc, Verset Laurine |
661993 |
FRONTIERS IN ONCOLOGY |
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer |
2021-03-05 |
10.3389/fonc.2020.581801 |
Gatti-Mays Margaret E., Gameiro Sofia R., Ozawa Yohei, Knudson Karin M., Hicks Kristin C., Palena Claudia, Cordes Lisa M., Steinberg Seth M., Francis Deneise, Karzai Fatima, Lipkowitz Stanley, Donahue Renee N., Jochems Caroline, Schlom Jeffrey, Gulley James L. |
661992 |
FRONTIERS IN ONCOLOGY |
Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients |
2021-03-05 |
10.3389/fonc.2020.625866 |
Li Yuan, Zhang Xiaolan, Gao Yan, Shang Chunliang, Yu Bo, Wang Tongxia, Su Junyan, Huang Cuiyu, Wu Yu, Guo Hongyan, Ha Chunfang |
661991 |
FRONTIERS IN ONCOLOGY |
Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development |
2021-03-05 |
10.3389/fonc.2021.639259 |
Li Haoyi, Huang Huawei, Zhang Xiaokang, Wang Yonggang, Ren Xiaohui, Cui Yong, Sui Dali, Lin Song, Jiang Zhongli, Zhang Guobin |
661990 |
FRONTIERS IN ONCOLOGY |
Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models |
2021-03-05 |
10.3389/fonc.2021.639528 |
Cheng Qianwen, Cai Li, Zhang Yuyang, Chen Lei, Hu Yu, Sun Chunyan |
661989 |
FRONTIERS IN ONCOLOGY |
Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy |
2021-03-05 |
10.3389/fonc.2020.537526 |
Zhang Li-xiang, Luo Pan-quan, Chen Lei, Song Dong-da, Xu A-man, Xu Peng, Xu Jia |